Vaccines Targeting Amyloid-β and Tau in Alzheimer’s Disease: Preventive vaccines targeting Aβ and tau are being developed to slow or even halt Alzheimer’s disease progression in individuals at a high risk. This evidence concerns the gene MAPT and early-onset autosomal dominant Alzheimer disease.